Breaking News, Collaborations & Alliances

Swarm Oncology Partners with Cellex to Advance T Cell Therapies for Solid Cancers

Aim to accelerate clinical timelines, reduce manufacturing bottlenecks, and enhance scalability, to bring Swarm's T cell therapies to patients in need.

Author Image

By: Charlie Sternberg

Associate Editor

Swarm Oncology Ltd., a biotechnology company, has partnered with Cellex Cell Professionals GmbH, a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy (CGT) manufacturing, to accelerate the development and manufacturing of its T cell therapies for advanced solid cancers. Through this partnership, Cellex will supply cellular starting material and oversee process transfer, GMP manufacturing, and quality control. Additionally, Cellex will provide regu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters